INNODIA is happy to announce that the Ver-A-T1D study has successfully randomized 135 participants.
The study is now closed to recruitment and will focus on the all-important follow-up of those in the study.
INNODIA is very much aware of the efforts it takes from both the participants to visit the medical center for follow-up and all study teams to get everything in place. This study can and will provide researchers with priceless and relevant data, which INNODIA will keep all people involved informed about.
IT REMAINS KEY for participants to keep respecting and attending all visits as originally planned. INNODIA can only generate knowledge about the disease development of type 1 diabetes if you stay true to this utmost important research till the very end.